We believe all people, particularly those who live with complex conditions, deserve new and better therapeutic options, and for the approximately 37,000 adult patients who have been diagnosed with idiopathic hypersomnia and are actively seeking care, this launch is a sign of hope the population has yet to see.

By helping to bridge the gaps that can sometimes occur between academics and companies when conducting clinical translational research, the SU2C Catalyst program embodies the type of multisectoral partnerships that we at Jazz know are integral to addressing some of the largest hurdles in healthcare.

As part of our commitment to the cancer community, Jazz actively seeks out and listens to patients, physicians, care teams and advocacy groups for insights that could help develop new or better standards of care for rare and difficult-to-treat cancers.

This month, we have been uplifting the voices of our LGBTQ+ colleagues, educating allies on queer history and commemorating the spirit of resistance –and resilience –with which Pride began.

Jazz employees came together last week for a virtual, global celebration in honor of Asian and Pacific Islander Heritage Month, led by our All Dimensions of Diversity Employee Resource Team and our Pan-Asian affinity forum.

Celebrate Diversity Month is a timely opportunity to help diverse communities of people gain a deeper understanding and appreciation of each other and to encourage conversation and education on the importance of diversity, equity and inclusion (DEI) in our workplaces.